-
1
-
-
27144496368
-
Understanding the symptoms of the common cold and influenza
-
Eccles, R.: Understanding the symptoms of the common cold and influenza. Lancet Infect. Dis. 5, 718-25 (2005). doi:10.1016/S1473-3099(05)70270-X
-
(2005)
Lancet Infect. Dis.
, vol.5
, pp. 718-725
-
-
Eccles, R.1
-
5
-
-
0015193295
-
Antigenic variation in influenza virus. Biology and chemistry
-
Webster, R.G., Laver, W.G.: Antigenic variation in influenza virus. Biology and chemistry. Prog. Med. Virol. 13, 271-338 (1971)
-
(1971)
Prog. Med. Virol.
, vol.13
, pp. 271-338
-
-
Webster, R.G.1
Laver, W.G.2
-
6
-
-
0035969777
-
The evolution of human influenza viruses
-
Hay, A.J., Gregory, V., Douglas, A.R., Lin, Y.P.: The evolution of human influenza viruses. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356, 1861-70 (2001). doi: 10.1098/rstb.2001.0999
-
(2001)
Philos. Trans. R. Soc. Lond. B Biol. Sci
, vol.356
, pp. 1861-1870
-
-
Hay, A.J.1
Gregory, V.2
Douglas, A.R.3
Lin, Y.P.4
-
7
-
-
84856872356
-
Aflunov(®): A prepandemic influenza vaccine
-
Gasparini, R., Amicizia, D., Lai, P.L., Panatto, D.: Aflunov(®): a prepandemic influenza vaccine. Expert Rev. Vaccines 11, 145-57 (2012). doi:10.1586/erv.11.170
-
(2012)
Expert Rev. Vaccines
, vol.11
, pp. 145-157
-
-
Gasparini, R.1
Amicizia, D.2
Lai, P.L.3
Panatto, D.4
-
8
-
-
40849130832
-
Current and future antiviral therapy of severe seasonal and avian influenza
-
Beigel, J., Bray, M.: Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res. 78, 91-102 (2008). doi:10.1016/j.antiviral.2008.01.003
-
(2008)
Antiviral Res
, vol.78
, pp. 91-102
-
-
Beigel, J.1
Bray, M.2
-
9
-
-
84865159167
-
Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
-
Jefferson, T., et al.: Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst. Rev. 18, 1 (2012). doi:10.1002/14651858.CD008965.pub3
-
(2012)
Cochrane Database Syst. Rev.
, vol.18
, pp. 1
-
-
Jefferson, T.1
-
10
-
-
79960067097
-
Influenza vaccines have a short but illustrious history of dedicated science enabling the rapid global production of A/Swine (H1N1) vaccine in the current pandemic
-
Del Giudice, G., Rappuoli, R. (eds.), Birkhauser Inc, Basel
-
Oxford, J., Gilbert, A., Lambkin-Williams, R.: Influenza vaccines have a short but illustrious history of dedicated science enabling the rapid global production of A/Swine (H1N1) vaccine in the current pandemic. In: Del Giudice, G., Rappuoli, R. (eds.) Influenza Vaccines for the Future, pp. 115-147. Birkhauser Inc, Basel (2011)
-
(2011)
Influenza Vaccines for the Future
, pp. 115-147
-
-
Oxford, J.1
Gilbert, A.2
Lambkin-Williams, R.3
-
11
-
-
84863645945
-
Influenza vaccine: An effective preventive vaccine for developing countries. Hum
-
Verma, R., Khanna, P., Chawla, S.: Influenza vaccine: an effective preventive vaccine for developing countries. Hum. Vaccin. Immunother. 8, 675-8 (2012). doi:10.4161/hv.19516
-
(2012)
Vaccin. Immunother.
, vol.8
, pp. 675-678
-
-
Verma, R.1
Khanna, P.2
Chawla, S.3
-
15
-
-
0010037635
-
Growth of influenza virus in the allantoic cavity of the chick embryo
-
Burnet, F.M.: Growth of influenza virus in the allantoic cavity of the chick embryo. Aust. J. Exp. Biol. Med. Sci. 19, 291-295 (1941)
-
(1941)
Aust. J. Exp. Biol. Med. Sci
, vol.19
, pp. 291-295
-
-
Burnet, F.M.1
-
16
-
-
0034705225
-
A DNA transfection system for generation of influenza A virus from eight plasmids
-
Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G., Webster, R.G.: A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. U.S.A. 97, 6108-6113 (2000). doi: 10.1073/pnas. 100133697
-
(2000)
Proc. Natl. Acad. Sci. U.S.A.
, vol.97
, pp. 6108-6113
-
-
Hoffmann, E.1
Neumann, G.2
Kawaoka, Y.3
Hobom, G.4
Webster, R.G.5
-
17
-
-
84957626859
-
-
17 to 21 October, Proposed Generic Protocol for the Calibration of Seasonal/Pandemic Influenza Antigen Working Reagents by WHO Essential Regulatory Laboratories (WHO/BS/2011.2183)
-
Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G., Webster, R.G.: Expert Committee on Biological Standardization Geneva, 17 to 21 October 2011 Proposed Generic Protocol for the Calibration of Seasonal/Pandemic Influenza Antigen Working Reagents by WHO Essential Regulatory Laboratories (WHO/BS/2011.2183). http://www.who.int/biologicals/expert_committee/BS2011.2183_Flu_vax_ERL_cali-bration_protocol.pdf
-
(2011)
Expert Committee on Biological Standardization Geneva
-
-
Hoffmann, E.1
Neumann, G.2
Kawaoka, Y.3
Hobom, G.4
Webster, R.G.5
-
19
-
-
68149119549
-
Egg-based production of influenza vaccine: 30 years of commercial experience
-
Matthews, J.T.: Egg-Based production of influenza vaccine: 30 years of commercial experience. The Bridge 36, 17-24 (2006)
-
(2006)
The Bridge
, vol.36
, pp. 17-24
-
-
Matthews, J.T.1
-
20
-
-
34247167856
-
Cell-culture-based vaccine production: Technological options
-
Rappuoli, R.: Cell-culture-based vaccine production: technological options. The Bridge 36, 25-30 (2006)
-
(2006)
The Bridge
, vol.36
, pp. 25-30
-
-
Rappuoli, R.1
-
21
-
-
79960073261
-
Cell culture-derived influenza vaccines
-
Del Giudice, G., Rappuoli, R. (eds.), Birkhauser Inc, Basel
-
Dormitzer, P.R.: Cell culture-derived influenza vaccines. In: Del Giudice, G., Rappuoli, R. (eds.) Influenza Vaccines for the Future, pp. 293-312. Birkhauser Inc, Basel (2011)
-
(2011)
Influenza Vaccines for the Future
, pp. 293-312
-
-
Dormitzer, P.R.1
-
22
-
-
0032078697
-
-
Vaccine, pii: S0264-410X(97)00301-0
-
Kistner, O., Barrett, P.N., Mundt, W., Reiter, M., Schober-Bendixen, S., Dorner, F.: Development of a mammalian cell (Vero) derived candidate influenza virus vaccine. Vaccine 16, 960-968 (1998). pii: S0264-410X(97)00301-0
-
(1998)
Development of a Mammalian Cell (Vero) Derived Candidate Influenza Virus Vaccine
, vol.16
, pp. 960-968
-
-
Kistner, O.1
Barrett, P.N.2
Mundt, W.3
Reiter, M.4
Schober-Bendixen, S.5
Dorner, F.6
-
23
-
-
0030839203
-
Immunogenicity and reactogenicity of influenza subunit vaccines produced in MDCK cells or fertilised chicken eggs
-
Palache, A.M., Brands, R., van Scharrenburg, G.: Immunogenicity and reactogenicity of influenza subunit vaccines produced in MDCK cells or fertilised chicken eggs. J. Infect. Dis. 176(Suppl 1), S20-S23 (1997)
-
(1997)
J. Infect. Dis
, vol.176
-
-
Palache, A.M.1
Brands, R.2
Van Scharrenburg, G.3
-
24
-
-
0016815519
-
A single radial-immunodiffusion technique for the assay of influenza hemagglutinin antigen
-
Schild, G.C., Wood, J.M., Newman, R.W.: A single radial-immunodiffusion technique for the assay of influenza hemagglutinin antigen. WHO Bull. 52, 223-231 (1975)
-
(1975)
WHO Bull
, vol.52
, pp. 223-231
-
-
Schild, G.C.1
Wood, J.M.2
Newman, R.W.3
-
25
-
-
0017620604
-
Application of an improved single radial-immunodiffusion technique for the assay of influenza hemagglutinin antigen content of whole virus and subunit vaccines
-
Wood, J.M., Schild, G.C., Newman, R.W., Seagroatt, V.: Application of an improved single radial-immunodiffusion technique for the assay of influenza hemagglutinin antigen content of whole virus and subunit vaccines. Dev. Biol. Stand. 39, 193-200 (1977)
-
(1977)
Dev. Biol. Stand.
, vol.39
, pp. 193-200
-
-
Wood, J.M.1
Schild, G.C.2
Newman, R.W.3
Seagroatt, V.4
-
26
-
-
67349113974
-
-
WHO Technical Report Series, No. 927, Annex 3
-
Wood, J.M., Schild, G.C., Newman, R.W., Seagroatt, V.: Recommendations for the production and control of influenza vaccine (inactivated) © World Health Organization WHO Technical Report Series, No. 927, Annex 3 (2005), http://www.who.int/vaccine_research/diseases/influenza/TRS_927_ANNEX_3_Influenza_2005.pdf
-
(2005)
Recommendations for the Production and Control of Influenza Vaccine (Inactivated) © World Health Organization
-
-
Wood, J.M.1
Schild, G.C.2
Newman, R.W.3
Seagroatt, V.4
-
28
-
-
84866665202
-
Improving influenza vaccines
-
Sambhara, S., Rappuoli, R.: Improving influenza vaccines. Expert Rev. Vaccines 11, 871-872 (2012). doi: 10.1586/erv. 12.79
-
(2012)
Expert Rev. Vaccines
, vol.11
, pp. 871-872
-
-
Sambhara, S.1
Rappuoli, R.2
-
29
-
-
84861823317
-
New technologies for influenza vaccines
-
Dormitzer, P.R., Tsai, T.F., Del Giudice, G.: New technologies for influenza vaccines. Hum. Vaccin. Immunother. 8, 45-58 (2012). doi:10.4161/hv.8.1.18859
-
(2012)
Hum. Vaccin. Immunother.
, vol.8
, pp. 45-58
-
-
Dormitzer, P.R.1
Tsai, T.F.2
Del Giudice, G.3
-
30
-
-
84862531587
-
Cell culture-derived influenza vaccines from Vero cells: A new horizon for vaccine production
-
Montomoli, E., et al.: Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production. Expert Rev. Vaccines 11, 587-94 (2012). doi: 10.1586/erv. 12.24
-
(2012)
Expert Rev. Vaccines
, vol.11
, pp. 587-594
-
-
Montomoli, E.1
-
31
-
-
84867792555
-
Exploring synergies between academia and vaccine manufacturers: A pilot study on how to rapidly produce vaccines to combat emerging pathogens
-
Strecker, T., et al.: Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens. Clin. Chem. Lab. Med. 50, 1275-9 (2012). doi:10.1515/cclm-2011-0650
-
(2012)
Clin. Chem. Lab. Med
, vol.50
, pp. 1275-1279
-
-
Strecker, T.1
-
32
-
-
84857050827
-
-
Geneva, Switzerland, 14-16 June 2010. Influenza Other Respi. Viruses
-
WHO Writing Group, Ampofo W. K. et al.: Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010. Influenza Other Respi. Viruses. 6, 142-152 (2012). doi: 10.1111/j. 1750-2659.2011.00277.x
-
(2012)
Improving Influenza Vaccine Virus Selection: Report of a WHO Informal Consultation Held at WHO Headquarters
, vol.6
, pp. 142-152
-
-
Ampofo, W.K.1
-
34
-
-
79954891276
-
Optimization and qualification of a quantitative reversed-phase HPLC method for hemagglutinin in influenza preparations and its comparative evaluation with biochemical assays
-
Lorbetskie, B., et al.: Optimization and qualification of a quantitative reversed-phase HPLC method for hemagglutinin in influenza preparations and its comparative evaluation with biochemical assays. Vaccine 29, 3377-89 (2011). doi:10.1016/j.vaccine.2011.02.090
-
(2011)
Vaccine
, vol.29
, pp. 3377-3389
-
-
Lorbetskie, B.1
-
35
-
-
42649130016
-
Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry
-
Williams, T.L., et al.: Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry. Vaccine 26, 2510-20 (2008). doi:10.1016/j.vaccine.2008.03.014
-
(2008)
Vaccine
, vol.26
, pp. 2510-2520
-
-
Williams, T.L.1
-
36
-
-
84857455818
-
Recombinant protein vaccines produced in insect cells
-
Cox, M.M.: Recombinant protein vaccines produced in insect cells. Vaccine 30, 1759-66 (2012). doi:10.1016/j.vaccine.2012.01.016
-
(2012)
Vaccine
, vol.30
, pp. 1759-1766
-
-
Cox, M.M.1
-
37
-
-
79951812398
-
Evaluation of the safety, reactoge-nicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age
-
Baxter, R., et al.: Evaluation of the safety, reactoge-nicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age. Vaccine 29, 2272-8 (2011). doi:10.1016/j.vaccine.2011.01.039
-
(2011)
Vaccine
, vol.29
, pp. 2272-2278
-
-
Baxter, R.1
-
39
-
-
84866679937
-
Virus-like particles as universal influenza vaccines. Expert
-
Kang, S.M., Kim, M.C., Compans, R.W.: Virus-like particles as universal influenza vaccines. Expert Rev. Vaccines 11, 995-1007 (2012). doi:10.1586/erv.12.70
-
(2012)
Rev. Vaccines
, vol.11
, pp. 995-1007
-
-
Kang, S.M.1
Kim, M.C.2
Compans, R.W.3
-
40
-
-
65449144444
-
Influenza virus-like particle vaccines. Expert
-
Haynes, J.R.: Influenza virus-like particle vaccines. Expert Rev. Vaccines 8, 435-45 (2009). doi:10.1586/erv.09.8
-
(2009)
Rev. Vaccines
, vol.8
, pp. 435-445
-
-
Haynes, J.R.1
-
41
-
-
80053013845
-
Live attenuated influenza vaccine-a review
-
Gasparini, R., Amicizia, D., Lai, P.L., Panatto, D.: Live attenuated influenza vaccine-a review. J. Prev. Med. Hyg. 52, 95-101 (2011)
-
(2011)
J. Prev. Med. Hyg
, vol.52
, pp. 95-101
-
-
Gasparini, R.1
Amicizia, D.2
Lai, P.L.3
Panatto, D.4
-
42
-
-
70349437154
-
Comparative efficacy of inactivated and live attenuated influenza vaccines
-
Monto, A.S., et al.: Comparative efficacy of inactivated and live attenuated influenza vaccines. N. Engl. J. Med. 361, 1260-7 (2009). doi:10.1056/NEJMoa0808652
-
(2009)
N. Engl. J. Med
, vol.361
, pp. 1260-1267
-
-
Monto, A.S.1
-
45
-
-
84867608670
-
Novel viral vectored vaccines for the prevention of influenza
-
Lambe, T.: Novel viral vectored vaccines for the prevention of influenza. Mol. Med. 18, 1153-60 (2012). doi:10.2119/molmed.2012.00147
-
(2012)
Mol. Med.
, vol.18
, pp. 1153-1160
-
-
Lambe, T.1
-
46
-
-
79960059589
-
Emulsion-based adjuvants for improved influenza vaccines
-
Del Giudice, G., Rappuoli, R. (eds.), Birkhauser Inc, Basel
-
O’Hagan, D.T., Tsai, T., Reed, S.: Emulsion-based adjuvants for improved influenza vaccines. In: Del Giudice, G., Rappuoli, R. (eds.) Influenza Vaccines for the Future, pp. 327-357. Birkhauser Inc, Basel (2011)
-
(2011)
Influenza Vaccines for the Future
, pp. 327-357
-
-
O’hagan, D.T.1
Tsai, T.2
Reed, S.3
-
47
-
-
67651115689
-
Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant
-
Vesikari, T., Pellegrini, M., Karvonen, A., Groth, N., Borkowski, A., et al.: Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant. Pediatr. Infect. Dis. J. 28, 563-571 (2009). doi: 10.1097/INF.0b013e31819d6394
-
(2009)
Pediatr. Infect. Dis. J.
, vol.28
, pp. 563-571
-
-
Vesikari, T.1
Pellegrini, M.2
Karvonen, A.3
Groth, N.4
Borkowski, A.5
-
48
-
-
80054024974
-
Oil-in-water emulsion adjuvant with influenza vaccine in young children
-
Vesikari, T., Knuf, M., Wutzler, P., Karvonen, A., Kieninger-Baum, D., et al.: Oil-in-water emulsion adjuvant with influenza vaccine in young children. N. Engl. J. Med. 365, 1406-16 (2011). doi:10.1056/NEJMoa1010331
-
(2011)
N. Engl. J. Med
, vol.365
, pp. 1406-1416
-
-
Vesikari, T.1
Knuf, M.2
Wutzler, P.3
Karvonen, A.4
Kieninger-Baum, D.5
-
49
-
-
84865337848
-
Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: A comparative cohort study
-
Heikkinen, T., Young, J., van Beek, E., Franke, H., Verstraeten, T., et al.: Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study. Am. J. Obstet. Gynecol. 207, 177.e1-8 (2012). doi:10.1016/j.ajog.2012.07.007
-
(2012)
Am. J. Obstet. Gynecol.
, vol.207
, Issue.177
-
-
Heikkinen, T.1
Young, J.2
Van Beek, E.3
Franke, H.4
Verstraeten, T.5
-
50
-
-
84861826001
-
The rationale for quadrivalent influenza vaccines. Hum
-
Ambrose, C.S., Levin, M.J.: The rationale for quadrivalent influenza vaccines. Hum. Vaccin. Immunother. 8, 81-88 (2012). doi:10.4161/hv.8.1.17623
-
(2012)
Vaccin. Immunother
, vol.8
, pp. 81-88
-
-
Ambrose, C.S.1
Levin, M.J.2
-
51
-
-
84870044640
-
The coming era of quadrivalent human influenza vaccines: Who will benefit?
-
Barr, I.G., Jelley, L.L.: The coming era of quadrivalent human influenza vaccines: who will benefit? Drugs 72, 2177-85 (2012). doi:10.2165/11641110-000000000-00000
-
(2012)
Drugs
, vol.72
, pp. 2177-2185
-
-
Barr, I.G.1
Jelley, L.L.2
-
52
-
-
84866669366
-
Universal influenza vaccine: The holy grail? Expert Rev
-
Shaw, A.R.: Universal influenza vaccine: the holy grail? Expert Rev. Vaccines 11, 923-927 (2012). doi: 10.1586/erv. 12.73
-
(2012)
Vaccines
, vol.11
, pp. 923-927
-
-
Shaw, A.R.1
-
53
-
-
77649274431
-
Research and development of universal influenza vaccines
-
Du, L., Zhou, Y., Jiang, S.: Research and development of universal influenza vaccines. Microbes Infect. 12, 280-6 (2010). doi:10.1016/j.micinf.2010.01.001
-
(2010)
Microbes Infect
, vol.12
, pp. 280-286
-
-
Du, L.1
Zhou, Y.2
Jiang, S.3
-
54
-
-
81555228636
-
Novel vaccines against influenza viruses
-
Kang, S.M., Song, J.M., Compans, R.W.: Novel vaccines against influenza viruses. Virus Res. 162, 31-38 (2011). doi:10.1016/j.virusres.2011.09.037
-
(2011)
Virus Res
, vol.162
, pp. 31-38
-
-
Kang, S.M.1
Song, J.M.2
Compans, R.W.3
-
56
-
-
9244240275
-
Serum antibody responses after intradermal vaccination against influenza
-
Belshe, R.B., Newman, F.K., Cannon, J., Duane, C., Treanor, J., et al.: Serum antibody responses after intradermal vaccination against influenza. N. Engl. J. Med. 351, 2286-94 (2004). doi:10.1056/NEJMoa043555
-
(2004)
N. Engl. J. Med
, vol.351
, pp. 2286-2294
-
-
Belshe, R.B.1
Newman, F.K.2
Cannon, J.3
Duane, C.4
Treanor, J.5
-
57
-
-
9244240268
-
Dose sparing with intradermal injection of influenza vaccine
-
Kenney, R.T., Frech, S.A., Muenz, L.R., Villar, C.P., Glenn, G.M.: Dose sparing with intradermal injection of influenza vaccine. N. Engl. J. Med. 351, 2295-301 (2004). doi: 10.1056/NEJMoa043540
-
(2004)
N. Engl. J. Med.
, vol.351
, pp. 2295-2301
-
-
Kenney, R.T.1
Frech, S.A.2
Muenz, L.R.3
Villar, C.P.4
Glenn, G.M.5
-
58
-
-
79851480211
-
Intradermal influenza vaccine and new devices: A promising chance for vaccine improvement
-
Ansaldi, F., Durando, P., Icardi, G.: Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement. Expert Opin. Biol. Ther. 11, 415-27 (2011). doi:10.1517/14712598.2011.557658
-
(2011)
Expert Opin. Biol. Ther.
, vol.11
, pp. 415-427
-
-
Ansaldi, F.1
Durando, P.2
Icardi, G.3
|